STOCK TITAN

Axcelis Tech Ord Stock Price, News & Analysis

ACLS Nasdaq

Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.

Axcelis Technologies Inc (NASDAQ: ACLS) delivers critical ion implantation systems and semiconductor manufacturing solutions to leading global chipmakers. This page provides investors and industry professionals with a centralized hub for official company announcements, operational updates, and strategic developments.

Access timely updates including earnings reports, product launches, technology partnerships, and service expansions. Our curated collection ensures you stay informed about ACLS's role in advanced logic, silicon carbide processing, and semiconductor equipment innovation.

Discover press releases covering operational milestones, customer collaborations, and advancements in process control technologies. All content is verified for accuracy and relevance to support informed analysis of ACLS's market position and industry contributions.

Bookmark this page for direct access to Axcelis Technologies' latest news. Check regularly for updates on equipment deployments, aftermarket service initiatives, and strategic developments shaping semiconductor manufacturing.

Rhea-AI Summary

Axcelis Technologies (Nasdaq: ACLS) has announced significant progress in the power device segment with multiple shipments of its Purion H200 Si 200mm and SiC Power Series™ 150mm high current implanters to major power device chipmakers in Asia. These systems are intended for high-volume production in the automotive sector, which is experiencing rapid growth.

Executive Vice President Bill Bintz stated that the power device segment is projected to comprise 30% to 40% of their system sales in 2022, highlighting the company's commitment to support electric vehicle technology through advanced manufacturing solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.88%
Tags
none
-
Rhea-AI Summary

Axcelis Technologies (NASDAQ: ACLS) is set to participate in the 14th Annual CEO Summit on July 13, 2022, taking place at the St. Regis Hotel in San Francisco, CA. This event allows accredited investors and research analysts to engage with the management teams of various participating companies. Axcelis, a leader in ion implantation solutions for the semiconductor industry, will make presentation materials available on its investor page. Early RSVP is advised as space is limited, with the registration deadline on July 1, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
conferences
-
Rhea-AI Summary

Axcelis Technologies (Nasdaq: ACLS) reported multiple shipments of Purion M™ medium current implanters, enhancing its presence in the semiconductor industry. These include follow-on orders and three new placements across the US, Europe, and Asia, shipped in Q2 2022. Executive VP Bill Bintz noted that the mature process technology market continues to be robust, indicating potential revenue growth from these new tool placements. This strategic move aims to expand the company's customer base and revenues in a vital segment of the industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.42%
Tags
none
Rhea-AI Summary

Axcelis Technologies (NASDAQ: ACLS) has announced its participation in several upcoming investor conferences. Key events include the 22nd Annual B. Riley Institutional Investor Conference on May 25 in Beverly Hills, CA, featuring a fireside chat by management. Other conferences include the Craig-Hallum Institutional Investor Conference on June 1, the Cowen Technology, Media & Telecom Conference on June 2, and the Stifel 2022 Cross Sector Insight Conference on June 8, where management will also present and conduct meetings. A live webcast will be available for the Stifel event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.29%
Tags
conferences
-
Rhea-AI Summary

Axcelis Technologies reported strong first-quarter results for 2022, with revenue of $203.6 million, slightly down from Q4 2021. The company achieved an operating profit of $48.9 million and net income of $41.6 million, or $1.22 per diluted share. A record backlog of $625.1 million and bookings of $315.5 million were reported, alongside cash of $297.9 million. The company anticipates exceeding $850 million in revenue for 2022. Despite supply chain challenges affecting margins, an optimistic outlook for the second quarter predicts revenues between $205-215 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.86%
Tags
-
Rhea-AI Summary

Axcelis Technologies (Nasdaq: ACLS) announced the shipment of two Purion H™ high current implanter evaluation systems in Q2 2022 to major chipmakers in Asia. These systems will assist in the production of DRAM memory and mature process technology devices. President and CEO Mary Puma highlighted the growth opportunities presented by these installations, emphasizing the superior process control and productivity offered by the Purion H technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.84%
Tags
none
Rhea-AI Summary

Axcelis Technologies (Nasdaq: ACLS), headquartered in Beverly, Mass., announced multiple shipments of its Purion Dragon™ high current implanter to semiconductor manufacturers in Asia, including follow-on orders and new customers. The Purion Dragon features advanced orthogonal beam optics tailored for critical implant steps in advanced memory and logic applications. This shipment, occurring in the first and second quarters of 2022, supports existing customer capacity expansion and marks entry into new markets. Executive VP Bill Bintz emphasized the implanter's capabilities and the productivity gains it delivers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.32%
Tags
none
-
Rhea-AI Summary

Axcelis Technologies, Inc. (Nasdaq: ACLS) will release its financial results for the first quarter of 2022 on May 4, 2022, at 4:00 p.m. ET. Following this, the company will host a conference call on May 5, 2022, at 8:30 a.m. ET, accessible via an audio webcast on its Investors page. Interested parties can join the call by dialing in at least 15 minutes prior to ensure connection. The company specializes in high-productivity solutions for the semiconductor industry, particularly in ion implantation systems.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.31%
Tags
conferences earnings
-
Rhea-AI Summary

On March 31, 2022, Axcelis Technologies (Nasdaq: ACLS) announced follow-on shipments of its Purion XE™ and Purion M™ implanters to a major power device chipmaker in Japan. These systems are meant for the high-volume production of 300mm thin silicon wafer-based MOSFET and IGBT devices used in automotive and power management applications. Executive VP Bill Bintz stated that the Purion Power Series' unique capabilities position Axcelis for growth in this market and they aim to enhance their footprint in Japan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
none
Rhea-AI Summary

Axcelis Technologies (Nasdaq: ACLS) announced several shipments of its Purion VXE high-energy systems to top CMOS image sensor manufacturers in Asia.

The Purion VXE, an advanced energy solution, is now recognized as the process tool of record in the image sensor sector. CEO Mary Puma highlighted that Axcelis holds a strong position in the growing image sensor market, which benefits from trends in IoT, mobile, and automotive sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.94%
Tags
none

FAQ

What is the current stock price of Axcelis Tech Ord (ACLS)?

The current stock price of Axcelis Tech Ord (ACLS) is $80.04 as of August 29, 2025.

What is the market cap of Axcelis Tech Ord (ACLS)?

The market cap of Axcelis Tech Ord (ACLS) is approximately 2.6B.
Axcelis Tech Ord

Nasdaq:ACLS

ACLS Rankings

ACLS Stock Data

2.57B
30.90M
1.64%
105.16%
16.82%
Semiconductor Equipment & Materials
Special Industry Machinery, Nec
Link
United States
BEVERLY